Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Cantor Fitzgerald
Moodys
Accenture
Express Scripts
Farmers Insurance
US Department of Justice
Colorcon
Citi
Mallinckrodt

Generated: February 23, 2018

DrugPatentWatch Database Preview

FURADANTIN Drug Profile

« Back to Dashboard

Which patents cover Furadantin, and what generic alternatives are available?

Furadantin is a drug marketed by Casper Pharma Llc and Procter And Gamble and is included in two NDAs.

The generic ingredient in FURADANTIN is nitrofurantoin. There are twenty drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the nitrofurantoin profile page.
Drug patent expirations by year for FURADANTIN
Pharmacology for FURADANTIN
Ingredient-typeNitrofurans
Drug ClassNitrofuran Antibacterial
Medical Subject Heading (MeSH) Categories for FURADANTIN

US Patents and Regulatory Information for FURADANTIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Casper Pharma Llc FURADANTIN nitrofurantoin SUSPENSION;ORAL 009175-001 Approved Prior to Jan 1, 1982 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Procter And Gamble FURADANTIN nitrofurantoin TABLET;ORAL 008693-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Procter And Gamble FURADANTIN nitrofurantoin TABLET;ORAL 008693-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Federal Trade Commission
Fish and Richardson
Baxter
Daiichi Sankyo
Harvard Business School
Moodys
Julphar
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot